Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 91,886 shares at $66.66 ($6.1M) on 2020-07-22, disclosed to the SEC on 2020-07-23.
Open-market sale of $6.1M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.06 | 3,021 | $197K | 3.2% |
| 2 | $65.06 | 3,021 | $197K | 3.2% |
| 3 | $65.07 | 300 | $20K | 0.3% |
| 4 | $65.49 | 1,380 | $90K | 1.5% |
| 5 | $65.49 | 1,380 | $90K | 1.5% |
| 6 | $65.53 | 400 |
| $26K |
| 0.4% |
| 7 | $66.50 | 1,151 | $77K | 1.2% |
| 8 | $66.50 | 1,151 | $77K | 1.2% |
| 9 | $66.66 | 12,217 | $814K | 13.2% |
| 10 | $66.66 | 12,217 | $814K | 13.2% |
| 11 | $66.77 | 4,228 | $282K | 4.6% |
| 12 | $66.77 | 4,228 | $282K | 4.6% |
| 13 | $67.28 | 2,623 | $176K | 2.9% |
| 14 | $67.28 | 2,623 | $176K | 2.9% |
| 15 | $67.39 | 17,175 | $1.2M | 18.8% |
| 16 | $67.39 | 17,175 | $1.2M | 18.8% |
| 17 | $67.48 | 3,798 | $256K | 4.2% |
| 18 | $67.48 | 3,798 | $256K | 4.2% |
| Total | $66.89 avg | 91,886 | $6.1M | 100% |
| Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |
| NVCR | SELL | 2019-11-06 | $6.4M | — | Filing → |